Oyster Point Pharma Inc (OYST) Inventory Turnover Ratio, from third quarter 2022 to third quarter 2021, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Oyster Point Pharma Inc   (NASDAQ: OYST)
 

Oyster Point Pharma Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Oyster Point Pharma Inc inventory turnover ratio, the Oyster Point Pharma Inc 's ability to sell and replace its inventory in the third quarter 2022, sequentially increased to 0.76 in the third quarter 2022, yet the ratio remained below the average, as OYST's market remain challenging.Average inventory processing period, for the Oyster Point Pharma Inc in Sep 30 2022 quarter, has decreased to 480 days, compare to 487 days, in the Jun 30 2022 quarter.

Within Healthcare sector 407 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 0 in the second quarter 2022, to 1888.

OYST Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Oyster Point Pharma Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OYST Inventory Turnover Ratio (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Inventory Growth - - - - -
Y / Y Cost of Sales Growth - - - - -
Inventory Turnover Ratio (TTM) 0.76 0.75 0.73 1 -
OYST's Total Ranking # 1888 # 0 # 1862 # 0 # 0
Average inventory processing period 480 484 499 364 -
Seq. Inventory Growth 4.73 % 62.31 % -32.73 % - -
Seq. Cost of Sales Growth 2.9 % 289.88 % -77.97 % - -




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 25
Healthcare Sector # 408
Overall Market # 1888

Inventory Turnover Ratio Statistics
High Average Low
0.79 0.79 0.79
(Sep 30 2022)  



OYST Company Profile >> Back to OYST Efficiency Comparisons >> Compare OYST Inventory Turnover Ratio to its Competitors

Financial Statements
Oyster Point Pharma Inc 's Inventories $ 7 Millions Visit OYST's Balance sheet
Oyster Point Pharma Inc 's Cost of Revenues TTM $ 5 Millions Visit OYST's Income Statement
What are OYST's Sales? Visit OYST's Sales by Segment

Other Inventory Turnover Ratios
Oyster Point Pharma Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
OYST's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for OYST's Competitors
Inventory Turnover Ratio for OYST's Suppliers
Inventory Turnover Ratio for OYST's Customers

You may also want to know
OYST's Sales Growth Rates OYST's Pe Price to earnings ratio OYST's Receivables Turnover Ratio OYST's Stock Quote
OYST's Net Income Growth Rates OYST's Ps Price to Sales ratio OYST's Sales per Employee OYST's Asset Turnover Ratio
OYST's Net Margin OYST's Pb Price to Book ratio OYST's Financial Strength Ratios OYST's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2022 Inventories at quarter ending Sep 30 2022
Apyx Medical Corp  1.77 $ 15.682  Millions$ 9  Millions
Pacira Biosciences inc   1.77 $ 176.386  Millions$ 100  Millions
Establishment Labs Holdings Inc   1.76 $ 50.544  Millions$ 29  Millions
Conmed Corporation  1.75 $ 473.335  Millions$ 270  Millions
Co diagnostics Inc   1.75 $ 7.452  Millions$ 4  Millions
Amicus Therapeutics inc   1.74 $ 37.066  Millions$ 21  Millions
Hyperfine Inc   1.70 $ 7.446  Millions$ 4  Millions
Phenomex Inc   1.70 $ 26.203  Millions$ 15  Millions
Taro Pharmaceutical Industries Ltd  1.70 $ 268.212  Millions$ 158  Millions
Alpha Pro Tech Ltd   1.69 $ 41.134  Millions$ 24  Millions
Nanostring Technologies Inc   1.68 $ 64.399  Millions$ 38  Millions
Icad Inc  1.67 $ 8.144  Millions$ 5  Millions
Acadia Pharmaceuticals Inc   1.66 $ 10.197  Millions$ 6  Millions
Bruker Corporation  1.66 $ 1,224.400  Millions$ 740  Millions
Femasys Inc   1.65 $ 0.421  Millions$ 0  Millions
Treace Medical Concepts Inc   1.64 $ 21.108  Millions$ 13  Millions
Assertio Holdings inc   1.62 $ 17.627  Millions$ 11  Millions
Procyon Corporation  1.62 $ 1.323  Millions$ 1  Millions
10x Genomics Inc   1.61 $ 106.518  Millions$ 66  Millions
Venus Concept Inc   1.57 $ 34.791  Millions$ 22  Millions
Halozyme Therapeutics Inc   1.57 $ 118.771  Millions$ 76  Millions
Yunhong Green Cti Ltd   1.57 $ 13.274  Millions$ 8  Millions
Inari Medical Inc   1.57 $ 39.658  Millions$ 25  Millions
Kiniksa Pharmaceuticals International Plc  1.56 $ 20.052  Millions$ 13  Millions
Ani Pharmaceuticals Inc  1.54 $ 136.357  Millions$ 88  Millions
Repligen Corp  1.53 $ 337.178  Millions$ 220  Millions
Edwards Lifesciences Corporation  1.53 $ 1,132.000  Millions$ 739  Millions
Seer Inc   1.51 $ 7.723  Millions$ 5  Millions
Cv Sciences Inc   1.49 $ 11.707  Millions$ 8  Millions
Xtant Medical Holdings Inc   1.48 $ 25.340  Millions$ 17  Millions

Date modified: 2026-08-29T17:41:26+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.